Role of 3D Echocardiography in Cardiac Surgery: Strengths and Limitations
Role of 3D Echocardiography in Cardiac Surgery: Strengths and Limitations
DOI 10.1007/s40140-017-0226-5
Cardiac Surgery and Three-Dimensional The inherent physical properties of ultrasound and with
Echocardiography that the limitations of ultrasound imaging in general are equal-
ly applicable to 3D and 2D echocardiography. Additionally,
General Strengths and Limitations there are specific 3D-based artifacts such as stitching artifacts,
dropout, “blurring” or thickening, blooming, and rail road
Two-dimensional echocardiography to visualize the 3D struc- artifacts [8–10]. Dropout artifacts can mimic valvular perfora-
ture of the heart requires cognitive reconstruction from multi- tions and periprosthetic leaks [11].
ple 2D images. This is no longer required in 3D echocardiog- Another limitation comes with displaying 3D echocardio-
raphy. Further, while 2D echocardiography only reveals cross- graphic images on a 2D screen. In doing so, colors are used to
sectional views of the heart, 3D echocardiography is more give a sense of depth and reality [12••]. Therefore, accurate
akin to a Cartesian coordinate system [6••], enabling us to measurements cannot be made in RT 3D mode [13].
display the anatomic view of the heart. This simplifies com-
munication between physicians and allows for better orienta- Specific Strengths and Limitations (See Table 1)
tion, which is particularly helpful for image-guided interven-
tional procedures [2]. Left Ventricle Volume and Function
Because ultrasound propagation is equal in both 2D and 3D
echocardiography, the use of more Cartesian coordinate-like Simultaneous multiplane mode allows the recommended bi-
data to improve spatial orientation leads to reduced temporal plane measurement for ejection fraction of the same heartbeat,
resolution. Practically, the echocardiographer using 3D echo- whereas in 2D TEE assessment, it can only be performed in
cardiography has to decide between the optimal temporal and two different heartbeats [14].
spatial resolutions when imaging specific cardiac structures. With FV mode and multiple beat acquisitions, the left ven-
Both temporal and spatial resolutions play a role in the tricular volume and function can be more accurately deter-
quality of images produced by 3D echocardiography. Images mined by 3D than by 2D echocardiography when compared
need to be of adequate quality to allow qualitative and quan- to other image modalities like multidetector computed tomog-
titative assessment. Temporal resolution is displayed as vol- raphy (MDCT) or cardiac magnetic resonance imaging
umes per time unit (volume rate), and this can be increased by (CMRI) [15••]. Three-dimensional echocardiography is more
decreasing the volume size (sector) imaged. Spatial resolution accurate than both contrast enhanced 2D echocardiography
can be improved by reducing the volume acquired or by in- and 2D echocardiography alone in the measurement of LV
creasing the number of scan lines through the volume. ejection fraction, but still underestimates LV volumes com-
Increasing the number of scan lines for a specific volume will pared to CMRI [16]. The strength of left ventricular assess-
reduce its temporal resolution. ment with 3D echocardiography is that no geometric assump-
Different 3D modalities are available (i.e., wide-sector tion is necessary and that it is unaffected by foreshortening
zoom, narrow sector, full volume (FV) mode with and without [14]. The limitations are the lower temporal resolution and
color Doppler). The technical aspect of these different modal- that no normal values for 3D TEE are available so far.
ities will not be discussed in detail in this article, but it is Image acquisition time to assess LV function and volume is
explained elsewhere [7••]. equally between both 3D and 2D. But, analysis of the 3D data
Mitral valve ME 0–120° ± CFD Multiplane, Zoom, FV Morphology (pathology), function, quantification—EROA and MVA
Aortic valve ME SAX and LAX views ± CFD Multiplane, Zoom, Live Valvular surgery and interventions esp. transcatheter
valvular replacements (TAVR)
Tricuspid valve ME 4C, 0°–30°, TG SAX (40°) Multiplane, Zoom, Live Unstudied (transcatheter procedures experimental)
Pulmonary valve UE 90°, ME 3C 120° ± CFD Multiplane, Zoom Limited visualization with TEE
IAS ME 0° view Multiplane, Zoom, FV Atrial septal defect, patent foramen ovale
LV ME 0°–120° views Multiplane, FV Volume, mass, EF, dysynchrony, deformation parameters
RV ME 0°–120° Multiplane, FV Volume, EF
LAA ME 0°, 45°, 60°, 90° Multiplane, Live, Zoom Thrombus
set takes on average 2 min longer [17]. In addition, a special measurement of the MV area is as accurate as with 2D TEE
software package for 3D analysis, not automatically included [32].
when buying a 3D system, is required.
Especially advantageous in the perioperative setting, nearly Localization of Paravalvular Leakage
all left ventricular dimensions can be measured based on a
single FV data set when using 3D TEE. This may be important Paravalvular leaks can be exactly located [33] and quantified
in cardiac surgery when the patient is either unstable or there is [34].
not enough time for a comprehensive 2D TEE examination
[18]. Multislice imaging of the ventricle can be performed, Aortic Valve
and regional wall motion and function can be assessed using
this single data set. Three-dimensional echocardiography can accurately display
the anatomy of the aortic valve in most patients and simplify
Right Ventricle Volume and Function communication between physicians [35], but in some patients,
the imaging is limited due to acoustic shadowing [8] and echo
The complex geometry of the right ventricle makes it impos- dropout especially in degenerative calcified aortic cusps [9••].
sible to evaluate right ventricular ejection fraction (EF) using Subvalvular aortic membranous structures as well as dy-
2D TEE. For experienced echocardiographers with access to namic left ventricular outflow tract (LVOT) obstruction can be
special software, it is recommended to use 3D-derived right diagnosed by 3D echocardiography [36], but low temporal
ventricular EF [14]. Good accuracy and correlation for 3D resolution may miss the dynamic obstruction [37].
right ventricular function in cardiac surgical patients with pre- Assessment of left ventricular outflow area with 3D echo-
operative 3D transthoracic echocardiography examinations cardiography has been shown to correlate better with multi-
have been shown in the perioperative setting [19, 20]. The slice computed tomography (MSCT) compared to 2D echo-
main limitations are the need for special software and image cardiography [38, 39] and is, therefore, recommended [40••].
quality. Sizing of transcatheter (transcatheter valvular replacements
(TAVR)) valves is discussed in the section on transcatheter
Mitral Valve procedures/interventional procedures.
Pathology can be assessed by 2D and additionally by 3D
The non-planar anatomy of the mitral valve (MV) complex TEE before aortic root, valve-sparing aortic, or valve repair
lends itself to 3D assessment. It is more intuitive to assess the surgery [24••, 41].
MV using 3D echocardiography than to reconstruct this three-
dimensional structure using multiple 2D views [21, 22]. The Quantification of Aortic Valve Disease (Aortic Regurgitation
MV can be displayed from the left atrial side and the left and Aortic Stenosis)
ventricle side using one 3D echocardiography image or data
set [7••]. Assessment of the mechanism of MV pathology can In aortic stenosis, 3D TEE can be used to measure left ven-
be done accurately [23, 24]; and 3D TEE is especially superior tricular outflow area and diameter [40••]. Semi-automated 3D
to 2D TEE in viewing complex MVanatomy and determining measurements seem to be better as compared to direct
pathology [25••, 26]. planimetry [42]. The underestimation of the LVOT area in
Three-dimensional MV assessment especially for MV re- the 2D method may lead to overestimation of aortic stenosis.
pair surgery can be used to predict the probability of success- Therefore, 3D echocardiography may have an impact on sur-
ful MV repair and to assess the result after repair [6••, 27], gical decision making in these cases [39, 43]. Recent recom-
both leading to optimal outcomes after surgery [28]. mendations suggest the use of 3D TEE or MSCT to measure
the LVOT and to use this measurement in the quantification of
Quantification of Mitral Valve Disease ( Mitral Regurgitation aortic valve area [40••].
and Mitral Stenosis) The use of 3D color flow is not recommended in quantifi-
cation of aortic regurgitation due to the low temporal and
Color flow Doppler in FV mode can be used to measure the spatial resolutions, except in patients with multiple jets [41].
VC area (VCA) and the proximal isovelocity surface area In these patients, overestimations or underestimations of the
(PISA) by planimetry [24••, 29], overcoming the caveats of jet size may occur.
flow-derived calculation in 2D TEE [30]. The most important
limitations are the temporal and spatial resolutions and cum- Tricuspid Valve
bersome offline analysis [24••].
Three-dimensional TEE is remarkable in its ability to as- The assessment of the tricuspid valve (TV) and its pathology
sess commissural fusion [31] in rheumatic MV disease, and its has to include assessment of the right ventricle and right
294 Curr Anesthesiol Rep (2017) 7:291–298
TEE with its simultaneous biplane mode is used for correct the capabilities of 3D imaging [76]. Combined TEE and fluo-
transseptal puncture [57, 61]. roscopy merged/fused images may play a role in improved
outcomes [28, 54].
Left Atrial Interventions Three-dimensional strain and strain rate as parameters of
myocardial deformation for the assessment of the left ventri-
Intra-atrial Septum and Left Atrial Appendix Three-dimen- cle, right ventricle, and left atrium will play an important role
sional TEE is superior to 2D TEE in the spatial information in chamber quantification in the future [77, 78•].
that it provides to delineate the variant anatomy of a patent
foramen ovale (PFO) and of atrial septal defects (ASD). The
en-face image of the intra-atrial septum allows for spatial ori- Conclusion
entation and counting of defects. RT 3D TEE is also very
suitable to guide the intervention. Offline MPR is useful for For the first time, RT 3D TEE allows for the anatomical dis-
correct measurement of ASD size through precise alignment, play of most cardiac structures and pathologies, therefore fa-
can indicate rim deficiencies, and allows measurement rela- cilitating improved communication between physicians. It ad-
tionships to important structures like the aorta [62•]. ditionally allows for more accurate quantification of some
The sizing of the left atrial appendix (LAA) can be done by stenotic as well as regurgitant pathologies. Further develop-
RT 3D TEE [63]. Two-dimensional TEE significantly under- ment in 3D technology and the definition of normal values are
estimates the maximal LAA orifice compared to RT 3D TEE the next steps to increase the clinical value of RT 3D TEE.
preclosure and during the procedure [64]. Additionally, RT 3D
TEE is useful in ruling out a LAA thrombus [50]. Compliance with Ethical Standards
Infective Endocarditis and Cardiac/Aortic Sources Conflict of Interest Edwin Wilberforce Turton and Jörg Ender declare
they have no conflict of interest.
of Embolism
Human and Animal Rights and Informed Consent This article does
Infective endocarditis (IE) and its complications can readily be not contain any studies with human or animal subjects performed by any
diagnosed and further clarified by the use of intraoperative 2D of the authors.
TEE. Three-dimensional TEE FV and real-time modes reveal
Open Access This article is distributed under the terms of the Creative
pathology that is not readily seen with 2D echocardiography Commons Attribution 4.0 International License (http://
[65]. There is a good correlation between 3D TEE assessment creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
of pathology and corresponding operative findings [66]. distribution, and reproduction in any medium, provided you give appro-
Morphology and size of valvular vegetations can be assessed, priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
superior to 2D TEE [67].
Three-dimensional and multiplane imaging are suggested
to confirm or exclude cardiac masses in the cardiac chambers
References
[68].
Volumetric assessment of cardiac masses can be performed
with 3D echocardiography, and further detailed assessment is Papers of particular interest, published recently, have been
possible: looking at attachment and detailed morphology [69]. highlighted as:
Thromboembolism from the thoracic aorta and atheroma- • Of importance
tous plaque in the aortic arch should be visualized in 3D and •• Of major importance
multiplane images [70].
1. Matsumoto M, Oka Y, Lin YT, Strom J, Sonnenblick EH, Frater
RW. Transesophageal echocardiography; for assessing ventricular
Future Developments performance. N Y State J Med. 1979;79(1):19–21.
2. Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib
More complex percutaneous and transapical valve procedures G, Hoffman P, et al. Recommendations for transoesophageal echo-
cardiography: EACVI update 2014. Eur Heart J Cardiovasc
are attempted and periprocedural 3D TEE guidance may also
Imaging. 2014;15(4):353–65.
be useful in upcoming interventions [71–73]. 3. Pandian NG, Nanda NC, Schwartz SL, Fan P, Cao QL, Sanyal R,
Automated or semi-automated software for quantification et al. Three-dimensional and four-dimensional transesophageal
of the MV, for example, is feasible [74, 75], but the benefit of echocardiographic imaging of the heart and aorta in humans using
this sophisticated software needs further investigation before a computed tomographic imaging probe. Echocardiography.
1992;9(6):677–87.
routine clinical use. 4. Fischer GW, Salgo IS, Adams DH. Real-time three-dimensional
Hybrid imaging techniques with the different imaging mo- transesophageal echocardiography: the matrix revolution. J
dalities merged and used at the same time will also improve Cardiothorac Vasc Anesth. 2008;22(6):904–12.
296 Curr Anesthesiol Rep (2017) 7:291–298
5. Pothineni KR, Inamdar V, Miller AP, Nanda NC, Bandarupalli N, transesophageal echocardiography in the evaluation of right ven-
Chaurasia P, et al. Initial experience with live/real time three- tricular volumes and function in patients undergoing cardiac sur-
dimensional transesophageal echocardiography. Echocardiography. gery. J Am Soc Echocardiogr. 2011.
2007;24(10):1099–104. 20. Karhausen J, Dudaryk R, Phillips-Bute B, Rivera JD, De LF,
6.•• Mahmood F, Matyal R. A quantitative approach to the intraopera- Milano CA, et al. Three-dimensional transesophageal echocardiog-
tive echocardiographic assessment of the mitral valve for repair. raphy for perioperative right ventricular assessment. Ann Thorac
Anesth Analg. 2015;121(1):34–58. The importance of the intra- Surg. 2012;94(2):468–74.
operative echocardiographer’s role in assesings the mitral valve 21. Salcedo EE, Quaife RA, Seres T, Carroll JD. A framework for
pathology and quantify it. Plays a role in decision making be- systematic characterization of the mitral valve by real-time three-
fore and after the repair surgery dimensional transesophageal echocardiography. J Am Soc
7.•• Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Echocardiogr. 2009;22(10):1087–99.
et al. EAE/ASE recommendations for image acquisition and dis- 22. Jain S, Malouf JF. Incremental value of 3-D transesophageal echo-
play using three-dimensional echocardiography. J Am Soc cardiographic imaging of the mitral valve. Curr Cardiol Rep.
Echocardiogr. 2012;25(1):3–46. The recommendations from the 2014;16(1):439.
European and American experts, including the use of 3D TEE 23.•• Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM,
8. Le HT, Hangiandreou N, Timmerman R, Rice MJ, Smith WB, et al. Guidelines for performing a comprehensive transesophageal
Deitte L, et al. Imaging artifacts in echocardiography. Anesth echocardiographic examination: recommendations from the
Analg. 2016;122(3):633–46. American Society of Echocardiography and the Society of
9.•• Faletra FF, Ramamurthi A, Dequarti MC, Leo LA, Moccetti T, Cardiovascular Anesthesiologists. Anesth Analg. 2014;118(1):21–
Pandian N. Artifacts in three-dimensional transesophageal echocar- 68. Performing of 3D TEE is included in the guidelines
diography. J Am Soc Echocardiogr. 2014;27(5):453–62. Artifacts 24.•• Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E,
of three dimensional echocardiography, with the focus on spe- Grayburn PA, et al. Recommendations for noninvasive evaluation
cific artifacts during cardiac interventions of native valvular regurgitation: a report from the American Society
10.• Mahmood F, Jeganathan J, Saraf R, Shahul S, Swaminathan M, of Echocardiography Developed in Collaboration with the Society
Mackensen GB, et al. A practical approach to an intraoperative for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr.
three-dimensional transesophageal echocardiography examination. 2017. Including both echocardiography and CMRI imaging to
J Cardiothorac Vasc Anesth. 2016;30(2):470–90. Review article assess regurgitant valves, and the use of 3DE for both quantifi-
on the quantitative and qualitative assessment using intraoper- cation and qualification are recommended.
ative 3D TEE 25. Vegas A. Three-dimensional transesophageal echocardiography:
11. Saxena P, Malouf JF, Click R, Suri RM. 3D echocardiography in principles and clinical applications. Ann Card Anaesth.
cardiac surgery. J Card Surg. 2014;29(1):51–4. 2016;19(Supplement):S35–43.
12.•• Vegas A, Meineri M. Core review: three-dimensional transesopha- 26. Tada H, Masuta E, Mori M, Tsubokawa T, Konno T, Hayashi K,
geal echocardiography is a major advance for intraoperative clinical et al. Perfect correspondence of mitral valve perforation using real-
management of patients undergoing cardiac surgery: a core review. time 3-dimensional transesophageal echocardiography. J Am Coll
Anesth Analg. 2010;110(6):1548–73. Initial comprehensive re- Cardiol. 2012;59(21):1914.
view article on this specific topic 27. Maslow A, Mahmood F, Poppas A, Singh A. Three-dimensional
13. Eibel S, Turton E, Mukherjee C, Bevilacqua C, Ender J. Feasibility echocardiographic assessment of the repaired mitral valve. J
of measurements of valve dimensions in en-face-3D transesopha- Cardiothorac Vasc Anesth. 2014;28(1):11–7.
geal echocardiography. Int J Cardiovasc Imaging. 2017. doi:10. 28. Wamil M, Bull S, Newton J. The modern role of transoesophageal
1007/s10554-017-1141-z. echocardiography in the assessment of valvular pathologies. Echo
14.•• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande Res Pract. 2017. doi:10.1530/ERP-16-0034.
L, et al. Recommendations for cardiac chamber quantification by 29. Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, et al.
echocardiography in adults: an update from the American Society Diagnostic value of vena contracta area in the quantification of
of Echocardiography and the European Association of mitral regurgitation severity by color Doppler 3D echocardiogra-
Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. phy. Circ Cardiovasc Imaging. 2011;4(5):506–13.
2015;16(3):233–70. Chamber quantification should include 30. Berdejo J, Shiota M, Mihara H, Itabashi Y, Utsunomiya H, Shiota T.
3DE when applicable, and knowing it's advantages and Vena contracta analysis by color Doppler three-dimensional trans-
limitations esophageal echocardiography shows geometrical differences be-
15. Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. tween prolapse and pseudoprolapse in eccentric mitral regurgita-
Performance of 3-dimensional echocardiography in measuring left tion. Echocardiography. 2017;34(5):683–89.
ventricular volumes and ejection fraction: a systematic review and 31. Schlosshan D, Aggarwal G, Mathur G, Allan R, Cranney G. Real-
meta-analysis. J Am Coll Cardiol. 2012;59(20):1799–808. time 3D transesophageal echocardiography for the evaluation of
16. Rigolli M, Anandabaskaran S, Christiansen JP, Whalley GA. Bias rheumatic mitral stenosis. JACC Cardiovasc Imaging. 2011;4(6):
associated with left ventricular quantification by multimodality im- 580–8.
aging: a systematic review and meta-analysis. Open Heart. 32. Dreyfus J, Brochet E, Lepage L, Attias D, Cueff C, Detaint D, et al.
2016;3(1):e000388. Real-time 3D transoesophageal measurement of the mitral valve
17. Meris A, Santambrogio L, Casso G, Mauri R, Engeler A, Cassina T. area in patients with mitral stenosis. Eur J Echocardiogr.
Intraoperative three-dimensional versus two-dimensional echocar- 2011;12(10):750–5.
diography for left ventricular assessment. Anesth Analg. 33. Garcia-Fernandez MA, Cortes M, Garcia-Robles JA, Gomez de
2014;118(4):711–20. Diego JJ, Perez-David E, Garcia E. Utility of real-time three-dimen-
18. Ender A, Eibel S, Hasheminejad E, Scholz M, Kaisers UX, sional transesophageal echocardiography in evaluating the success
Mukherjee C, et al. Real-time 3 dimensional full volume data set of percutaneous transcatheter closure of mitral paravalvular leaks. J
: benefits in problem focused intraoperative transesophageal echo- Am Soc Echocardiogr. 2010;23(1):26–32.
cardiography. Anaesthesist. 2012;61(10):875–82. 34. Arribas-Jimenez A, Rama-Merchan JC, Barreiro-Perez M,
19. Fusini L, Tamborini G, Gripari P, Maffessanti F, Mazzanti V, Merchan-Gomez S, Iscar-Galan A, Martin-Garcia A, et al. Utility
Muratori M et al. Feasibility of intraoperative three-dimensional of real-time 3-dimensional transesophageal echocardiography in
Curr Anesthesiol Rep (2017) 7:291–298 297
the assessment of mitral paravalvular leak. Circ J. 2016;80(3):738– 50. Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn
44. RT, et al. EAE/ASE recommendations for the use of echocardiog-
35. Kim H, Bergman R, Matyal R, Khabbaz KR, Mahmood F. Three- raphy in new transcatheter interventions for valvular heart disease. J
dimensional echocardiography and en face views of the aortic Am Soc Echocardiogr. 2011;24(9):937–65.
valve: technical communication. J Cardiothorac Vasc Anesth. 51. Zamorano J, Pardo A. 3D-ECHO for TAVI: two arrows, just in
2013;27(2):376–80. case. Eur Heart J Cardiovasc Imaging. 2016;17(1):9–10.
36. Jiang L, Shakil O, Montealegre-Gallegos M, Jainandunsing JS, 52.• Hahn RT, Little SH, Monaghan MJ, Kodali SK, Williams M, Leon
Matyal R, Wang A, et al. Systolic anterior motion of the mitral MB, et al. Recommendations for comprehensive intraprocedural
valve and three-dimensional echocardiography. J Cardiothorac echocardiographic imaging during TAVR. JACC Cardiovasc
Vasc Anesth. 2015;29(1):149–50. Imaging. 2015;8(3):261–87. 3DE to size valves, identify landing
37. Hymel BJ, Townsley MM. Echocardiographic assessment of sys- zone and quantify paravalvular leaks
tolic anterior motion of the mitral valve. Anesth Analg. 53. Patel PA, Gutsche JT, Vernick WJ, Giri JS, Ghadimi K, Weiss SJ,
2014;118(6):1197–201. et al. The functional aortic annulus in the 3D era: focus on trans-
38. Gaspar T, Adawi S, Sachner R, Asmer I, Ganaeem M, Rubinshtein catheter aortic valve replacement for the perioperative echocardiog-
R, et al. Three-dimensional imaging of the left ventricular outflow rapher. J Cardiothorac Vasc Anesth. 2015;29(1):240–5.
tract: impact on aortic valve area estimation by the continuity equa- 54. Perk G, Kronzon I. Interventional echocardiography in structural
tion. J Am Soc Echocardiogr. 2012;25(7):749–57. heart disease. Curr Cardiol Rep. 2013;15(3):338.
39. Jainandunsing JS, Mahmood F, Matyal R, Shakil O, Hess PE, Lee J, 55. Debonnaire P, Delgado V, Bax JJ, Marsan NA. Tools & tech-
et al. Impact of three-dimensional echocardiography on classifica- niques—clinical: 3D transoesophageal echocardiography for
tion of the severity of aortic stenosis. Ann Thorac Surg. 2013;96(4): selecting and guiding in percutaneous mitral valve repair using
1343–8. MitraClip. EuroIntervention. 2014;10(7):884–6.
40.•• Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, 56.• Guarracino F, Baldassarri R, Ferro B, Giannini C, Bertini P,
Goldstein S, et al. Recommendations on the echocardiographic as- Petronio AS, et al. Transesophageal echocardiography during
sessment of aortic valve stenosis: a focused update from the MitraClip(R) procedure. Anesth Analg. 2014;118(6):1188–96.
European Association of Cardiovascular Imaging and the Increased value of 3D TEE in guiding this procedure
American Society of Echocardiography. J Am Soc Echocardiogr. 57. Cavalcante JL, Rodriguez LL, Kapadia S, Tuzcu EM, Stewart WJ.
2017;30(4):372–92. Updated Recommendations, the use of 3D Role of echocardiography in percutaneous mitral valve interven-
TTE and 3D TEE are recommended in imaging and quantifi- tions. JACC Cardiovasc Imaging. 2012;5(7):733–46.
cation of AS 58. Wunderlich NC, Beigel R, Siegel RJ. The role of echocardiography
41. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, during mitral valve percutaneous interventions. Cardiol Clin.
Grayburn PA, et al. Recommendations for noninvasive evaluation 2013;31(2):237–70.
of native valvular regurgitation: a report from the American Society 59. Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian
of Echocardiography Developed in Collaboration with the Society A, Messika-Zeitoun D, et al. Cardioband, a transcatheter surgical-
for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. like direct mitral valve annuloplasty system: early results of the
2017;30(4):303–71. feasibility trial. Eur Heart J. 2016;37(10):817–25.
42. Khalique OK, Hamid NB, White JM, Bae DJ, Kodali SK, Nazif 60. Mahmoud HM, Al-Ghamdi MA, Ghabashi AE. Real time three-
TM, et al. Impact of methodologic differences in three-dimensional dimensional transesophageal echocardiography guided coronary si-
echocardiographic measurements of the aortic annulus compared nus cannulation during CARILLON mitral annuloplasty device
with computed tomographic angiography before Transcatheter aor- therapy for a patient with chronic severe mitral regurgitation.
tic valve replacement. J Am Soc Echocardiogr. 2017;30(4):414–21. Echocardiography. 2015;32(1):181–3.
43. Jainandunsing JS, Shahul SS. Moderate-to-severe aortic stenosis 61. Perk G, Lang RM, Garcia-Fernandez MA, Lodato J, Sugeng L,
and three-dimensional echocardiography. J Cardiothorac Vasc Lopez J, et al. Use of real time three-dimensional transesophageal
Anesth. 2013;27(1):190–1. echocardiography in intracardiac catheter based interventions. J Am
44.• Hahn RT. State-of-the-art review of echocardiographic imaging in Soc Echocardiogr. 2009;22(8):865–82.
the evaluation and treatment of functional tricuspid regurgitation. 62.• Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE,
Circ Cardiovasc Imaging. 2016;9(12). Defining the role of 3D Hijazi ZM, et al. Guidelines for the echocardiographic assessment
TTE and TEE in evaluation of the Tricuspid valve. of atrial septal defect and patent foramen ovale: from the American
45. Muraru D, Surkova E, Badano LP. Revisit of functional tricuspid Society of Echocardiography and Society for Cardiac Angiography
regurgitation; current trends in the diagnosis and management. and Interventions. J Am Soc Echocardiogr. 2015;28(8):910–58.
Korean Circ J. 2016;46(4):443–55. Includes 3D TEE protocol for PFO and ASD assessment
46. Mahmood F, Kim H, Chaudary B, Bergman R, Matyal R, Gerstle J, 63. Yosefy C, Laish-Farkash A, Azhibekov Y, Khalameizer V, Brodkin
et al. Tricuspid annular geometry: a three-dimensional transesoph- B, Katz A. A new method for direct three-dimensional measure-
ageal echocardiographic study. J Cardiothorac Vasc Anesth. ment of left atrial appendage dimensions during transesophageal
2013;27(4):639–46. echocardiography. Echocardiography. 2016;33(1):69–76.
47. Faletra FF, Nucifora G, Ho SY. Imaging the atrial septum using 64. Goebel B, Wieg S, Hamadanchi A, Otto S, Jung C, Kretzschmar D,
real-time three-dimensional transesophageal echocardiography: et al. Interventional left atrial appendage occlusion: added value of
technical tips, normal anatomy, and its role in transseptal puncture. 3D transesophageal echocardiography for device sizing. Int J
J Am Soc Echocardiogr. 2011;24(6):593–9. Cardiovasc Imaging. 2016;32(9):1363–70.
48. Joshi D, Bicer EI, Donmez C, Hsiung MC, Nanda NC, Sadat K, 65. Vrettou AR, Zacharoulis A, Lerakis S, Kremastinos DT. Revealing
et al. Incremental value of live/real time three-dimensional trans- infective endocarditis complications by echocardiography: the val-
esophageal echocardiography over the two-dimensional technique ue of real-time 3D transesophageal echocardiography. Hell J
in the assessment of aortic aneurysm and dissection. Cardiol. 2013;54(2):147–9.
Echocardiography. 2012;29(5):620–30. 66. Yong MS, Saxena P, Killu AM, Coffey S, Burkhart HM, Wan SH,
49. Mahmood F, Shernan SK. Perioperative transoesophageal echocar- et al. The preoperative evaluation of infective endocarditis via 3-
diography: current status and future directions. Heart. dimensional transesophageal echocardiography. Tex Heart Inst J.
2016;102(15):1159–67. 2015;42(4):372–6.
298 Curr Anesthesiol Rep (2017) 7:291–298
67. Berdejo J, Shibayama K, Harada K, Tanaka J, Mihara H, 73. Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G.
Gurudevan SV, et al. Evaluation of vegetation size and its relation- Transcatheter treatment of severe tricuspid regurgitation with the
ship with embolism in infective endocarditis: a real-time 3-dimen- MitraClip system. Eur Heart J. 2016;37(10):849–53.
sional transesophageal echocardiography study. Circ Cardiovasc 74. Mackensen GB, Swaminathan M, Mathew JP. PRO editorial: PRO:
Imaging. 2014;7(1):149–54. three-dimensional transesophageal echocardiography is a major ad-
68. Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo vance for intraoperative clinical management of patients undergo-
Res Pract. 2016;3(4):R65–77. ing cardiac surgery. Anesth Analg. 2010;110(6):1574–8.
69. Zaragoza-Macias E, Chen MA, Gill EA. Real time three- 75. Noack T, Mukherjee C, Kiefer P, Emrich F, Vollroth M, Ionasec RI,
dimensional echocardiography evaluation of intracardiac masses. et al. Four-dimensional modelling of the mitral valve by real-time
Echocardiography. 2012;29(2):207–19. 3D transoesophageal echocardiography: proof of concept. Interact
70. Saric M, Armour AC, Arnaout MS, Chaudhry FA, Grimm RA, Cardiovasc Thorac Surg. 2015;20(2):200–8.
Kronzon I, et al. Guidelines for the use of echocardiography in 76. Quaife RA, Salcedo EE, Carroll JD. Procedural guidance using
the evaluation of a cardiac source of embolism. J Am Soc advance imaging techniques for percutaneous edge-to-edge mitral
Echocardiogr. 2016;29(1):1–42. valve repair. Curr Cardiol Rep. 2014;16(2):452.
71. Gafoor S, Petrescu OM, Lehr EJ, Puls C, Zhang M, Petersen JL II, 77. Howard-Quijano K, Salem A, Barkulis C, Mazor E, Scovotti JC,
et al. Percutaneous tricuspid valve regurgitation repair with the Ho JK, et al. Preoperative three-dimensional strain imaging iden-
MitraClip device using an edge-to-edge bicuspidization technique. tifies reduction in left ventricular function and predicts outcomes
J Invasive Cardiol. 2017;29(3):E30–E6. after cardiac surgery. Anesth Analg. 2017;124(2):419–28.
72. Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J,
78.• Skubas NJ, London MJ. We should train for strain. Anesth Analg.
Hansen L, et al. Transfemoral tricuspid valve repair using a percu-
2017;124(2):386–7. May be used intraoperatively in the future
taneous mitral valve repair system. J Am Coll Cardiol. 2016;67(7):
889–90.